Developing new DNA damage and repair inhibitors on the CLARIOstar Plus

  • Company/University: Artios Pharma, UK
  • Interviewee: Claire McWhirter
  • Products used: CLARIOstar Plus
  • Method: development and characterisation of new inhibitors, endpoint and kinetic fluorescence intensity assays, fluorescence polarisation, luminescence
go to top